North America Clinical Trials Market Benefits From a Robust U.S. Research Environment
According to Rohan Patil, who specializes in central laboratory testing services, biomarket and genomic analysis solutions, and specialty laboratory testing, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the North America clinical trials market. The global North America clinical trials market size was estimated at USD 55.48 billion in 2025 and is predicted to increase from USD 58.82 billion in 2026 to approximately USD 99.1 billion by 2035, expanding at a CAGR of 4.50% from 2026 to 2035. His analysis highlights the increasing adoption of biomarker-driven clinical trials, centralized laboratory testing services, integrated clinical data management platforms, and specialty bioanalytical testing services. The research also examines the competitive strategies of key industry participants, including IQVIA, Labcorp, Paraxel International, Syneos Health, and ICON plc, shaping the future by enabling precision-driven clinical research, advancing decentralized trials laboratory support, accelerating digital laboratory transformations, and enhancing real-time clinical data integration in the global North America clinical trials market.
Last Updated : 13 July 2026
Category: Healthcare Services
Insight Code: 6293
Format: PDF / PPT / Excel